期刊文献+

Increased bone mineral density in patients with nonalcoholic steatohepatitis 被引量:4

下载PDF
导出
摘要 AIM:To determine the relationship between non-alcoholic steatohepatitis(NASH)and bone mineral density(BMD).METHODS:A total of 38 patients(25 males)with a diagnosis of histologically proven NASH and 42 healthy controls(24 males)were enrolled in the study.Demographic features,clinical findings,complete blood count and routine biochemical analysis,as well as adrenal,thyroid and gonadal functions,were recorded.Additionally,intact parathormone,25-OH-vitamin-D3,tumor necrosis factor-α,interleukin-6,interleukin-1,in-sulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels were measured in both groups.Furthermore,lumbar spine and femoral neck BMD of both groups were measured by the dual-energy X-ray absorptiometry(DXA)method.RESULTS:The mean age was 41±12 years in the NASH group and 43±11 years in the control group.Among demographic features,waist circumference was significantly larger in the NASH group compared to the control group(P【0.019).Among laboratory parameters,serum triglyceride(P【0.008),alanine transaminase(P【0.0001),aspartate transaminase(P【0.001),alkaline phosphatase(P【0.016),gamma glutamyl transferase(P【0.0001),ferritin(P【0.001)and 25-OH-vitamin-D3levels(P【0.0001)were significantly higher in the NASH group compared to the control group.Lumbar BMD was significantly higher in the NASH group compared to the control group(1.057±0.119 g/cm2vs 0.941±0.133 g/cm2;P【0.001,respectively).In the NASH group,there was no significant relationship between BMD and fibrosis stage in liver biopsy.CONCLUSION:NASH increases BMD and may be related to an elevated serum 25-OH-vitamin D3 level. AIM:To determine the relationship between non-alcoholic steatohepatitis(NASH)and bone mineral density(BMD).METHODS:A total of 38 patients(25 males)with a diagnosis of histologically proven NASH and 42 healthy controls(24 males)were enrolled in the study.Demographic features,clinical findings,complete blood count and routine biochemical analysis,as well as adrenal,thyroid and gonadal functions,were recorded.Additionally,intact parathormone,25-OH-vitamin-D3,tumor necrosis factor-α,interleukin-6,interleukin-1,in-sulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels were measured in both groups.Furthermore,lumbar spine and femoral neck BMD of both groups were measured by the dual-energy X-ray absorptiometry(DXA)method.RESULTS:The mean age was 41±12 years in the NASH group and 43±11 years in the control group.Among demographic features,waist circumference was significantly larger in the NASH group compared to the control group(P<0.019).Among laboratory parameters,serum triglyceride(P<0.008),alanine transaminase(P<0.0001),aspartate transaminase(P<0.001),alkaline phosphatase(P<0.016),gamma glutamyl transferase(P<0.0001),ferritin(P<0.001)and 25-OH-vitamin-D3levels(P<0.0001)were significantly higher in the NASH group compared to the control group.Lumbar BMD was significantly higher in the NASH group compared to the control group(1.057±0.119 g/cm2vs 0.941±0.133 g/cm2;P<0.001,respectively).In the NASH group,there was no significant relationship between BMD and fibrosis stage in liver biopsy.CONCLUSION:NASH increases BMD and may be related to an elevated serum 25-OH-vitamin D3 level.
出处 《World Journal of Hepatology》 CAS 2013年第11期627-634,共8页 世界肝病学杂志(英文版)(电子版)
关键词 Non-alcoholic STEATOHEPATITIS HEPATIC OSTEODYSTROPHY Bone MINERAL density Non-alcoholic steatohepatitis Hepatic osteodystrophy Bone mineral density
  • 相关文献

参考文献34

  • 1Lucia Pacifico,Mario Bezzi,Concetta Valentina Lombardo,Sara Romaggioli,Flavia Ferraro,Stefano Bascetta,Claudio Chiesa.Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2013,19(25):4007-4014. 被引量:3
  • 2Joe George,Hosahithlu K Ganesh,Shrikrishna Acharya,Tushar R Bandgar,Vyankatesh Shivane,Anjana Karvat,Shobna J Bhatia,Samir Shah,Padmavathy S Menon,Nalini Shah.Bone mineral density and disorders of mineral metabolism in chronic liver disease[J].World Journal of Gastroenterology,2009,15(28):3516-3522. 被引量:16
  • 3Tugrul Purnak,Yavuz Beyazit,Ersan Ozaslan,Cumali Efe,Merve Hayretci.The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease[J]. Wiener klinische Wochenschrift . 2012 (15)
  • 4A. Arabi,R. Baddoura,R. El-Rassi,G. El-Hajj Fuleihan.PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly[J]. Osteoporosis International . 2012 (3)
  • 5Jeffrey R. Lewis,Smruti R. Mohanty.Nonalcoholic Fatty Liver Disease: A Review and Update[J]. Digestive Diseases and Sciences . 2010 (3)
  • 6Onpan Cheung,Arun J Sanyal.Recent advances in nonalcoholic fatty liver disease[J]. Current Opinion in Gastroenterology . 2009 (3)
  • 7Rudolf W. Gasser.Cholestasis and metabolic bone disease – a clinical review[J]Wiener Medizinische Wochenschrift (-),2008(1920).
  • 8David García-Galiano,Miguel A. Sánchez-Garrido,Isabel Espejo,José Luis Montero,Guadalupe Costán,Trinidad Marchal,Antonio Membrives,José M. Gallardo-Valverde,Juan R. Mu?oz-Casta?eda,Eugenio Arévalo,Manuel Mata,Jordi Muntané.IL-6 and IGF-1 are Independent Prognostic Factors of Liver Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients[J]. Obesity Surgery . 2007 (4)
  • 9Catherine M. Jankowski,Wendolyn S. Gozansky,Robert S. Schwartz,Daniel J. Dahl,John M. Kittelson,Stephen M. Scott,Rachael E. Van Pelt,Wendy M. Kohrt.Effects of Dehydroepiandrosterone Replacement Therapy on Bone Mineral Density in Older Adults: A Randomized, Controlled Trial[J]. The Journal of Clinical Endocrinology & Metabolism . 2006 (8)
  • 10Giovanni Targher,Lorenzo Bertolini,Luca Scala,Massimo Cigolini,Luciano Zenari,Giancarlo Falezza,Guido Arcaro.Associations between serum 25-hydroxyvitamin D 3 concentrations and liver histology in patients with non-alcoholic fatty liver disease[J]Nutrition Metabolism and Cardiovascular Diseases,2006(7).

二级参考文献38

  • 1Hay JE.Osteoporosis in liver diseases and after liver transplantation.J Hepatol 2003; 38:856-865.
  • 2Collier JD,Ninkovic M,Compston JE.Guidelines on the management of osteoporosis associated with chronic liver disease.Gut 2002; 50 Suppl 1:i1-i9.
  • 3Hay JE,Guichelaar MM.Evaluation and management of osteoporosis in liver disease.Clin Liver Dis 2005; 9:747-766,viii.
  • 4Sachdev S,Bhasin RC,Kumari CK,Reys M.A study of metabolic bone disorder in cirrhosis liver.J Assoc Physicians India 1976; 24:5-11.
  • 5Barger-Lux MJ,Heaney RP.Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption.J Clin Endocrinol Metab 2002; 87:4952-4956.
  • 6Nutrient requirements and recommended daily allowances for Indians:Report of the expert group of the Indian Council of Medical Research.National Institute of Nutrition,2000:41.
  • 7Leslie WD,Bernstein CN,Leboff MS.AGA technical review on osteoporosis in hepatic disorders.Gastroenterology 2003; 125:941-966.
  • 8Mithal A.Metabolic bone disorders.1st ed.Indian society of bone and mineral research,1998:213 -219.
  • 9Nordin BE.International patterns of osteoporosis.Clin Orthop Relat Res 1966; 45:17-30.
  • 10Vernejoul M.Bone structure and function.In:Geusens P,editor.Osteoporosis in clinical practice.A practical guide for diagnosis and treatment.London:Springer-Verlag,1998:1-4.

共引文献21

同被引文献25

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部